Skip to main content
Erschienen in: Journal of Endocrinological Investigation 7/2017

01.07.2017 | Original Article

Correlation between pre-ramadan glycemic control and subsequent glucose fluctuation during fasting in adolescents with Type 1 diabetes

verfasst von: B. Afandi, W. Kaplan, N. Al Hassani, S. Hadi, A. Mohamed

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 7/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Even though patients with type 1 diabetes mellitus (T1DM) are exempted from fasting, the vast majority elect to fast against the advice of their healthcare providers. We have previously reported the incidence of wide fluctuations in blood glucose (BG) along with “unrecognized” severe hypoglycemia during Ramadan fasting in adolescents with T1DM. This report compares the continuous glucose monitoring (CGM) data during fasting in adolescents with T1DM according to their Pre-Ramadan diabetes control.

Methods

Children and adolescents with T1DM who intended to fast the month of Ramadan were asked to wear the CGM during fasting for a minimum of 3 days. Hypoglycemia, hyperglycemia, and severe hyperglycemia were identified as BG <70 mg/dL (3.9 mmol/L), BG 201–300 mg/dL (11.2–16.7 mmol/L), or BG >300 mg/dL (16.7 mmol/L) respectively, while normoglycemia was identified as BG 70–200 mg/dL (3.9–11.1 mmol/L). Patients were categorized as well-controlled (Group 1) and poorly controlled (Group 2) if the pre-fasting HbA1C was ≤8% (64 mmol/mol) and >8%, respectively. We compared the mean BG and the percentages of time spent in hypoglycemia, hyperglycemia, and severe hyperglycemia between the two groups using Chi-square (significant difference when P value was <0.05).

Results

A total of 21 patients were enrolled (15 females), age 15 ± 4 years, duration of diabetes 6 ± 3 years, and HbA1C 8.5 ± 1.0% (70 mmol/mol). There were 7 subjects in Group 1, mean HbA1C 7.5 ± 0.4, and 14 subjects in Group 2, mean HbA1C 9.1 ± 0.9. The mean ± SD BG was 174 ± 76 mg/dL versus 199 ± 98, (P < 0.05) in Group 1 and Group 2, respectively. The percentages of hypoglycemia, hyperglycemia, and severe hyperglycemia were significantly higher in Group 2, while there was a higher percentage of normoglycemia in Group 1. The overall durations of hypoglycemia, hyperglycemia, and severe hyperglycemia in Group 2 were longer by 30, 14, and 135%, respectively, than those in Group 1.

Conclusions

Glycemic control before Ramadan in adolescents with T1 DM appears to correlate with blood glucose profile during Ramadan fasting. Our data suggest that optimal glycemic control before Ramadan may reduce the potential risks associated with fasting and minimize glucose fluctuation.
Literatur
1.
Zurück zum Zitat Salti I, Benard E, Detournay B et al (2004) A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care 27:2306–2311CrossRefPubMed Salti I, Benard E, Detournay B et al (2004) A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care 27:2306–2311CrossRefPubMed
2.
Zurück zum Zitat Babineaux SM, Toaima D, Boye KS et al (2015) Multi-country retrospective observational study of the management and outcomes of patients with Type 2 diabetes during Ramadan in 2010 (CREED). Diabet Med 32:819–828CrossRefPubMed Babineaux SM, Toaima D, Boye KS et al (2015) Multi-country retrospective observational study of the management and outcomes of patients with Type 2 diabetes during Ramadan in 2010 (CREED). Diabet Med 32:819–828CrossRefPubMed
3.
Zurück zum Zitat Kaplan W, Afandi B. (2015) Blood glucose fluctuation during Ramadan fasting in adolescents with Type 1 diabetes: findings of continuous glucose monitoring. Diabetes Care 38(10):e162–e163CrossRef Kaplan W, Afandi B. (2015) Blood glucose fluctuation during Ramadan fasting in adolescents with Type 1 diabetes: findings of continuous glucose monitoring. Diabetes Care 38(10):e162–e163CrossRef
5.
Zurück zum Zitat Al-Arouj M (2015) Risk stratification of Ramadan fasting in person with diabetes. J Pak Med Assoc 65:S18–S21 Al-Arouj M (2015) Risk stratification of Ramadan fasting in person with diabetes. J Pak Med Assoc 65:S18–S21
6.
Zurück zum Zitat Karges B, Kapellen T, Wagner VM, Steigleder-Schweiger C, Karges W, Holl RW, Rosenbauer J (2015) DPV Initiative. Glycated hemoglobin A1c as a risk factor for severe hypoglycemia in pediatric type 1 diabetes. Pediatr Diabetes. doi:10.1111/pedi.12348 Karges B, Kapellen T, Wagner VM, Steigleder-Schweiger C, Karges W, Holl RW, Rosenbauer J (2015) DPV Initiative. Glycated hemoglobin A1c as a risk factor for severe hypoglycemia in pediatric type 1 diabetes. Pediatr Diabetes. doi:10.​1111/​pedi.​12348
7.
Zurück zum Zitat Haynes A, Hermann JM, Miller KM, Hofer SE, Jones TW, Beck RW, Maahs DM, Davis EA, Holl RW (2016) T1D Exchange, WACDD and DPV registries. Severe hypoglycemia rates are not associated with HbA1c: a cross-sectional analysis of 3 contemporary pediatric diabetes registry databases. Pediatr Diabetes. doi:10.1111/pedi.12477 PubMed Haynes A, Hermann JM, Miller KM, Hofer SE, Jones TW, Beck RW, Maahs DM, Davis EA, Holl RW (2016) T1D Exchange, WACDD and DPV registries. Severe hypoglycemia rates are not associated with HbA1c: a cross-sectional analysis of 3 contemporary pediatric diabetes registry databases. Pediatr Diabetes. doi:10.​1111/​pedi.​12477 PubMed
8.
Zurück zum Zitat Al-Arouj M, Assaad-Khalil S, Buse J, Fahdil I, Fahmy M, Hafez S, Hassanein M, Ibrahim MA, Kendall D, Kishawi S, Al-Madani A, Nakhi AB, Tayeb K, Thomas A (2010) Recommendations for management of diabetes during Ramadan: update 2010. Diabetes Care 33(8):1895–1902. doi:10.2337/dc10-0896 CrossRefPubMedPubMedCentral Al-Arouj M, Assaad-Khalil S, Buse J, Fahdil I, Fahmy M, Hafez S, Hassanein M, Ibrahim MA, Kendall D, Kishawi S, Al-Madani A, Nakhi AB, Tayeb K, Thomas A (2010) Recommendations for management of diabetes during Ramadan: update 2010. Diabetes Care 33(8):1895–1902. doi:10.​2337/​dc10-0896 CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Kassem HS, Zantout MS, Azar ST (2005 Oct) Insulin therapy during Ramadan fast for Type 1 diabetes patients. J Endocrinol Invest 28(9):802–805CrossRefPubMed Kassem HS, Zantout MS, Azar ST (2005 Oct) Insulin therapy during Ramadan fast for Type 1 diabetes patients. J Endocrinol Invest 28(9):802–805CrossRefPubMed
11.
Zurück zum Zitat Kobeissy A, Zantout MS, Azar ST (2008 Aug) Suggested insulin regimens for patients with type 1 diabetes mellitus who wish to fast during the month of Ramadan. Clin Ther 30(8):1408–1415CrossRefPubMed Kobeissy A, Zantout MS, Azar ST (2008 Aug) Suggested insulin regimens for patients with type 1 diabetes mellitus who wish to fast during the month of Ramadan. Clin Ther 30(8):1408–1415CrossRefPubMed
12.
Zurück zum Zitat Deeb, Al Qahtani N, Attia S, Al Suwaidi H, Nagelkerke N (September 2016) Does reducing basal insulin during Ramadan fasting by children and adolescents with Type 1 diabetes decrease the risk of symptomatic hypoglycemia? Diabetes Technol Ther 18(9):539–542. doi:10.1089/dia.2016.0197 CrossRefPubMed Deeb, Al Qahtani N, Attia S, Al Suwaidi H, Nagelkerke N (September 2016) Does reducing basal insulin during Ramadan fasting by children and adolescents with Type 1 diabetes decrease the risk of symptomatic hypoglycemia? Diabetes Technol Ther 18(9):539–542. doi:10.​1089/​dia.​2016.​0197 CrossRefPubMed
13.
Zurück zum Zitat Bonora B, Maran A, Ciciliot S, Avogaro A, Fadini GP. Head-to-head comparison between flash and continuous glucose monitoring systems in outpatients With Type 1 diabetes. J Endocrinol Invest 39(12):1391–1399 Bonora B, Maran A, Ciciliot S, Avogaro A, Fadini GP. Head-to-head comparison between flash and continuous glucose monitoring systems in outpatients With Type 1 diabetes. J Endocrinol Invest 39(12):1391–1399
Metadaten
Titel
Correlation between pre-ramadan glycemic control and subsequent glucose fluctuation during fasting in adolescents with Type 1 diabetes
verfasst von
B. Afandi
W. Kaplan
N. Al Hassani
S. Hadi
A. Mohamed
Publikationsdatum
01.07.2017
Verlag
Springer International Publishing
Erschienen in
Journal of Endocrinological Investigation / Ausgabe 7/2017
Elektronische ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-017-0633-y

Weitere Artikel der Ausgabe 7/2017

Journal of Endocrinological Investigation 7/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.